Stimulation with low frequency (1.7 Hz) transcutaneous electric nerve stimulation (low-tens) increases motor function of the post-stroke paretic arm.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 9606771)

Published in Scand J Rehabil Med on June 01, 1998

Authors

L Sonde1, C Gip, S E Fernaeus, C G Nilsson, M Viitanen

Author Affiliations

1: Division of Geriatric Medicine, Karolinska Institute, Huddinge Hospital, Sweden.

Associated clinical trials:

Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke | NCT00142792

Articles by these authors

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med (1996) 10.44

A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (1998) 2.85

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology (2007) 2.63

Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci (1997) 2.59

The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol (2000) 2.37

Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls. Neurology (2009) 2.27

Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ (1996) 2.20

Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology (1997) 2.14

Validity of self-reported stroke : The Tromso Study. Stroke (2000) 2.09

Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology (1991) 2.05

Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ (1998) 1.96

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology (2006) 1.85

Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol (1994) 1.64

Premedication with midazolam delays recovery after ambulatory sevoflurane anesthesia in children. Anesth Analg (1999) 1.62

Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease. Biol Psychiatry (1996) 1.56

Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord (1998) 1.55

Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology (1992) 1.54

Institutionalization in the elderly: the role of chronic diseases and dementia. Cross-sectional and longitudinal data from a population-based study. J Clin Epidemiol (2001) 1.54

Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study. Am J Public Health (1998) 1.51

Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol (1999) 1.50

Altered blood-brain-barrier function in Alzheimer's disease? Acta Neurol Scand (1994) 1.44

TVT versus laparoscopic mesh colposuspension: 5-year follow-up results of a randomized clinical trial. Int Urogynecol J (2014) 1.41

[Double messages to persons with problems due to amalgam and computer screens]. Lakartidningen (1998) 1.40

[Persons with amalgam problems should be examined from different aspects]. Lakartidningen (1996) 1.38

Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. J Clin Epidemiol (1999) 1.38

PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease. Brain (2008) 1.34

Risk factors for late-onset Alzheimer's disease: a population-based, case-control study. Ann Neurol (1993) 1.29

Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study. Neurology (2011) 1.26

Accuracy of the Mini-Mental Status Examination as a screening test for dementia in a Swedish elderly population. Acta Neurol Scand (1993) 1.25

Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study. Am J Epidemiol (1999) 1.24

Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol (1999) 1.23

Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clin Endocrinol (Oxf) (1982) 1.20

Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol (1998) 1.18

Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc (1998) 1.17

Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. J Neural Transm Park Dis Dement Sect (1993) 1.15

Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project. Am J Epidemiol (1997) 1.13

Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices. Int J Gynecol Pathol (1986) 1.13

Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol (1996) 1.11

Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study. Dement Geriatr Cogn Disord (2006) 1.11

Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population. Neuroepidemiology (2004) 1.09

Variant Alzheimer's disease with spastic paraparesis: clinical characterization. Neurology (2000) 1.06

Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease. Neurosci Lett (1994) 1.06

Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis. A 2-year follow-up study. J Hepatol (2001) 1.06

Mortality in nondemented subjects with cognitive impairment: the influence of health-related factors. Am J Epidemiol (1999) 1.05

Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study. Eur J Neurol (2009) 1.03

Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005--a register-based approach. Diabet Med (2009) 1.03

Clinical diagnosis of Alzheimer's disease and other dementias in a population survey. Agreement and causes of disagreement in applying Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, Criteria. Arch Neurol (1992) 1.02

Pregnancy and delivery complications in the births of an unselected series of Finnish children with schizophrenic mothers. Acta Psychiatr Scand (1980) 1.02

Can a physician recognize an older driver with increased crash risk potential? J Am Geriatr Soc (1996) 1.01

Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis. J Neurol Sci (1996) 1.01

Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women. Neurosci Lett (2000) 1.00

Low blood pressure and incidence of dementia in a very old sample: dependent on initial cognition. J Am Geriatr Soc (1999) 0.99

Mild cognitive impairment in the population and physical health: data on 1,435 individuals aged 75 to 95. J Gerontol A Biol Sci Med Sci (2000) 0.99

Mini-Mental State Examination item scores as predictors of Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. J Gerontol A Biol Sci Med Sci (1997) 0.98

Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations. Exp Neurol (2001) 0.97

Broken small-gauge spinal needle. Anesth Analg (1997) 0.97

Serum and follicular fluid leptin during in vitro fertilization: relationship among leptin increase, body fat mass, and reduced ovarian response. J Clin Endocrinol Metab (1999) 0.96

Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication? Am J Epidemiol (2001) 0.96

Comparison of Abeta levels in the brain of familial and sporadic Alzheimer's disease. Neurochem Int (2009) 0.96

Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project. Neurology (2000) 0.96

Memory complaints of elderly people in a population survey: variation according to dementia stage and depression. J Am Geriatr Soc (1993) 0.95

Clinical staging of dementia in a population survey: comparison of DSM-III-R and the Washington University Clinical Dementia Rating Scale. Acta Psychiatr Scand (1992) 0.94

The pathogenesis of CADASIL: an update. J Neurol Sci (2004) 0.94

Care of demented patients with severe communication problems. Scand J Caring Sci (1991) 0.93

Association of stroke with dementia, cognitive impairment, and functional disability in the very old: a population-based study. Stroke (1998) 0.93

Low blood pressure and five-year mortality in a Stockholm cohort of the very old: possible confounding by cognitive impairment and other factors. Am J Public Health (1997) 0.92

Cognitive support at episodic encoding and retrieval: similar patterns of utilization in community-based samples of Alzheimer's disease and vascular dementia patients. J Clin Exp Neuropsychol (1999) 0.92

Effectiveness of the TVT procedure as a repeat mid-urethra operation for treatment of stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.92

Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study. Stroke (2000) 0.91

Attitudes and participation of the elderly in population surveys: data from a longitudinal study on aging and dementia in Stockholm. J Clin Epidemiol (1998) 0.91

Comparative quantitation of menstrual blood loss with a d-norgestrel-releasing iud and a Nova-T-copper device. Contraception (1977) 0.90

Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease. Neurosci Lett (1999) 0.90

Prior knowledge and face recognition in a community-based sample of healthy, very old adults. J Gerontol (1993) 0.90

Five years' experience with levonorgestrel-releasing IUDs. Contraception (1986) 0.90

Preconditions for communication in the care of bilingual demented persons. Int Psychogeriatr (1994) 0.90

Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL. Brain (2007) 0.89

Mild cognitive impairment--an early stage of Alzheimer's disease? J Neural Transm Suppl (1998) 0.89

Neurologic symptoms are common during gestation and puerperium in CADASIL. Neurology (2005) 0.89

Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke (1996) 0.89

Dementia and driving: an attempt at consensus. Alzheimer Dis Assoc Disord (1997) 0.89

Sevoflurane-maintained anesthesia induced with propofol or sevoflurane in small children: induction and recovery characteristics. Can J Anaesth (1999) 0.89

Episodic remembering in a population-based sample of nonagenarians: does major depression exacerbate the memory deficits seen in Alzheimer's disease? Psychol Aging (1996) 0.88

Prognosis for chronic obstructive pulmonary disease patients who receive long-term oxygen therapy. Int J Tuberc Lung Dis (1999) 0.88

Morbidity and comorbidity in relation to functional status: a community-based study of the oldest old (90+ years). J Am Geriatr Soc (2000) 0.88

Phenotype of a homozygous CADASIL patient in comparison to 9 age-matched heterozygous patients with the same R133C Notch3 mutation. Stroke (2001) 0.88

Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain (1998) 0.87

Survival in Finnish centenarians in relation to apolipoprotein E polymorphism. J Am Geriatr Soc (2001) 0.87

Blood pressure reduction, cardiovascular diseases, and cognitive decline in the mini-mental state examination in a community population of normal very old people: a three-year follow-up. J Clin Epidemiol (1998) 0.86

Autonomic dysfunction in Alzheimer's disease. Acta Neurol Scand (1995) 0.86

Sustained intrauterine release of levonorgestrel over five years. Fertil Steril (1986) 0.86

Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device. Fertil Steril (1984) 0.85

Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75+. Biol Psychiatry (1997) 0.85

A double-blind placebo-controlled study of the effects of amphetamine and physiotherapy after stroke. Cerebrovasc Dis (2001) 0.85

Effect of long-term oxygen therapy on cognitive and neurological dysfunction in chronic obstructive pulmonary disease. Eur Neurol (1999) 0.85

CYP2D6 and CYP2C19 genotypes in an elderly Swedish population. Eur J Clin Pharmacol (1998) 0.84

Predicting dementia from the Mini-Mental State Examination in an elderly population: the role of education. J Clin Epidemiol (1993) 0.84

An in vitro study to compare 5 different techniques for injection of the navicular bursa in the horse. Equine Vet J (2000) 0.84

Assessment of driving after stroke--a pluridisciplinary task. Accid Anal Prev (2007) 0.84

The environmental somatization syndrome. Psychosomatics (1995) 0.84